EDT Matinas BioPharma (MTNB) files to sell 16.9M shares of common stock for holdersStay Ahead of the Market: Discover outperforming ...

Shares of Matinas Biopharma Holdings, Inc. (NYSE:MTNB – Get Free Report) fell 6.6% during mid-day trading on Tuesday .The company traded as low as $0.53 and last traded at $0.56. 46,870 shares ...

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery ...

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward ...

Short interest in Matinas BioPharma Holdings Inc (AMEX:MTNB) decreased during the last reporting period, falling from 291.99K to 232.41K. This put 4.69% of the company's publicly available shares ...

In a recent Special Meeting held on Monday, Matinas BioPharma (NYSE:MTNB) Holdings, Inc. received shareholder approval on several significant proposals. The meeting, which was convened on April 4, ...

Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American:MTNB), a pharmaceutical company specializing in the development of drug delivery technologies with a current market capitalization of $3 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward ...

1 Day MTNB 0.16% DJIA 1.24% Russell 2K 1.39% Health Care/Life Sciences -0.59% ...